Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03977402 · ClinicalTrials.gov registry record
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
A clinical trial of Cancer and Cancer Risk, sponsored by New Mexico Cancer Research Alliance.
- Recruiting
- Registry status
- 47,500
- Enrollment target
- 1
- Study location
NCT03977402: Recruiting study of Cancer and Cancer Risk, sponsored by New Mexico Cancer Research Alliance.
NCT03977402 is a study of Cancer and Cancer Risk that is actively recruiting participants, run by New Mexico Cancer Research Alliance. The registered enrollment target is 47,500 participants, above the 3,414-participant average among 615 other Cancer trials with a reported enrollment target (1291% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03977402, a study of Cancer and Cancer Risk, is actively recruiting participants, sponsored by New Mexico Cancer Research Alliance.
- RECRUITING
- Registry status
- 47,500 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the Oncology Research Information Exchange Network (ORIEN) Consortium of academic medical centers, community hospital systems, and other health care providers. To bring new translational research to the community, the ORIEN consortium has initiated the ORIEN Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of patients with cancer or at risk of having cancer. This is not a treatment trial. It is a study designed to create a centralized data and tissue repository.
Primary Outcome
Establish a longitudinal clinical data repository that will contain information about patient demographics collected via surveys and questionnaires.
Conditions Studied
Interventions
- OTHER Biological specimen collection
Study Locations (1)
New Mexico
- University of New Mexico Comprehensive Cancer Center - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47,500 participants |
| Start Date | 2016-01-27 |
| Est. Completion | 2037-12-31 |
What NCT03977402 shows while recruiting
NCT03977402 is an observational study that tracks outcomes without assigning an intervention. Its 47,500 participants enrollment target places it among the larger protocols in the corpus, above the 3,414-participant average among 615 other Cancer trials with a reported enrollment target (1291% higher).
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Biological specimen collection is the first listed.
NCT03977402 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT03977402 about?
NCT03977402 is a clinical study titled "Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer". The overall objective of this study is to ultimately develop an improved standard of cancer care by facilitating new cancer research, clinical trials, new technology, new informatics solutions, and "personalized medicine" for the University of New Mexico Comprehensive Cancer Center (UNMCCC) and the ...
What is the current status of trial NCT03977402?
This trial is currently recruiting. The enrollment target is 47,500 participants. The study started on 2016-01-27. Estimated completion is 2037-12-31.
What conditions does trial NCT03977402 study?
This clinical trial studies the following conditions: Cancer, Cancer Risk.
What interventions are being tested in trial NCT03977402?
The interventions under investigation include: Biological specimen collection (OTHER).
Who is sponsoring clinical trial NCT03977402?
This trial is sponsored by New Mexico Cancer Research Alliance, which has 66 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03977402 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03977402's enrollment target sits among peer trials
47,500 11th of 615 higher than 605 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06655974 · 48,000 participants · NA
Predictive Modeling for Social Needs in Emergency Department Settings
- NCT06597968 · 45,991 participants
Evaluating the Real World Performance of an AI Based Lung Nodule Detection Tool
- NCT06824350 · 45,450 participants · NA
Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
- NCT05607732 · 45,257 participants · NA
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI